TW200512183A - 2-alkylidene-19-nor-vitamin d derivatives for the treatment of frailty, muscle damage or sarcopenia - Google Patents

2-alkylidene-19-nor-vitamin d derivatives for the treatment of frailty, muscle damage or sarcopenia

Info

Publication number
TW200512183A
TW200512183A TW093127919A TW93127919A TW200512183A TW 200512183 A TW200512183 A TW 200512183A TW 093127919 A TW093127919 A TW 093127919A TW 93127919 A TW93127919 A TW 93127919A TW 200512183 A TW200512183 A TW 200512183A
Authority
TW
Taiwan
Prior art keywords
sarcopenia
alkylidene
vitamin
frailty
muscle damage
Prior art date
Application number
TW093127919A
Other languages
English (en)
Inventor
Andrew George Lee
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TW200512183A publication Critical patent/TW200512183A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TW093127919A 2003-09-19 2004-09-15 2-alkylidene-19-nor-vitamin d derivatives for the treatment of frailty, muscle damage or sarcopenia TW200512183A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50450903P 2003-09-19 2003-09-19

Publications (1)

Publication Number Publication Date
TW200512183A true TW200512183A (en) 2005-04-01

Family

ID=34375511

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093127919A TW200512183A (en) 2003-09-19 2004-09-15 2-alkylidene-19-nor-vitamin d derivatives for the treatment of frailty, muscle damage or sarcopenia

Country Status (16)

Country Link
US (1) US20050065129A1 (zh)
EP (1) EP1667688A1 (zh)
JP (1) JP2007505882A (zh)
KR (1) KR20060040744A (zh)
CN (1) CN1852718A (zh)
AU (1) AU2004273659A1 (zh)
BR (1) BRPI0414564A (zh)
CA (1) CA2538993A1 (zh)
IL (1) IL174043A0 (zh)
MX (1) MXPA06002947A (zh)
NO (1) NO20061704L (zh)
NZ (1) NZ545632A (zh)
RU (1) RU2326674C2 (zh)
TW (1) TW200512183A (zh)
WO (1) WO2005027914A1 (zh)
ZA (1) ZA200601721B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106489971A (zh) * 2015-09-07 2017-03-15 江苏龙灯化学有限公司 一种除草组合物

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014004647A1 (en) * 2012-06-26 2014-01-03 Entia Biosciences, Inc. A nutritional approach to improving athletic performance and reducing injury with l-ergothioneine and/or vitamin d2
KR20150030673A (ko) * 2012-06-29 2015-03-20 위스콘신 얼럼나이 리서어치 화운데이션 속발성 부갑상선기능항진증을 치료하기 위한 2-메틸렌-19-노르-(20S)-1α,25-디히드록시비타민 D₃의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5086191A (en) * 1991-05-28 1992-02-04 Wisconsin Alumni Research Foundation Intermediates for the synthesis of 19-nor vitamin D compounds
JP2898882B2 (ja) * 1993-04-05 1999-06-02 ウイスコンシン アラムナイ リサーチ フオンデーシヨン ２−位に置換基を有する１９−ノル−ビタミンｄ３ 化合物
US5843928A (en) * 1997-03-17 1998-12-01 Wisconsin Alumni Research Foundation 2-alkylidene-19-nor-vitamin D compounds
NZ522909A (en) * 2000-05-31 2004-09-24 Wisconsin Alumni Res Found 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
US20030195175A1 (en) * 2002-03-25 2003-10-16 Deluca Hector F. Use of carbon-2-modified-vitamin D analogs to induce the formation of new bone

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106489971A (zh) * 2015-09-07 2017-03-15 江苏龙灯化学有限公司 一种除草组合物

Also Published As

Publication number Publication date
CA2538993A1 (en) 2005-03-31
MXPA06002947A (es) 2006-05-31
IL174043A0 (en) 2006-08-01
EP1667688A1 (en) 2006-06-14
RU2006107649A (ru) 2007-11-10
RU2326674C2 (ru) 2008-06-20
NZ545632A (en) 2009-09-25
JP2007505882A (ja) 2007-03-15
BRPI0414564A (pt) 2006-11-07
US20050065129A1 (en) 2005-03-24
CN1852718A (zh) 2006-10-25
KR20060040744A (ko) 2006-05-10
AU2004273659A1 (en) 2005-03-31
WO2005027914A1 (en) 2005-03-31
NO20061704L (no) 2006-06-19
ZA200601721B (en) 2007-07-25

Similar Documents

Publication Publication Date Title
GB0318447D0 (en) Therapeutic agents
IL168365A (en) Use of a rasagaline with or without riluzole for preparing a medicament for treating amyotrophic lateral sclerosis
IL175762A0 (en) Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
TW200635582A (en) Medicaments for the treatment or prevention of fibrotic diseases
SI2527315T1 (sl) Spojine, sestavki in metode za zdravljenje amiloidnih bolezni in sinukleinopatij, kot so Alzheimerjeva bolezen, diabetes tipa 2 in Parkinsonova bolezen
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
HK1089380A1 (en) Treatment of bacterial diseases of the respiratory organs by locally applying fluoroquinolones
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
SE0400184D0 (sv) New therapeutical use
TW200742580A (en) Methods for treating nephrolithiasis
IL177169A (en) Use of n-(2-aryl- propionyl)-sulfonamides for the preparation of medicaments for the treatment of spinal cord injury
ZA200609220B (en) Method of treating dry eye disorders and uveitis
TW200511999A (en) Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone
TW200512183A (en) 2-alkylidene-19-nor-vitamin d derivatives for the treatment of frailty, muscle damage or sarcopenia
NO20060655L (no) 2-alkyliden-19-Nor-vitamin D derivater for behandling av osteofeni eller osteoporose hos hannkjonn
SI1596879T1 (sl) Uporaba spojine kahalalida za pripravo zdravila za zdravljenje luskavice
AU2003255843A1 (en) 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain
EA200600989A1 (ru) Применение габоксадола для лечения бессонницы
PL1612210T3 (pl) Nowe analogi nitrobenzylotioinozyny
MXPA05013975A (es) Tratamiento de enfermedades asociadas con amiloide y epileptogenesis.
TW200501958A (en) A therapeutic agent for treating a behavioral disorder
TW200519078A (en) 2-alkylidene-19-nor-vitamin d derivatives for the treatment of a second hip fracture
HRP20050281A2 (en) Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes
HK1080768A1 (en) Use of epothilone derivatives for the treatment ofhyperparathyroidism